Last reviewed · How we verify

NCT04515251

Ultrasound Evaluation of Superior Mesenteric Artery Measurements in a Healthy Pediatric Population

Recruiting now Last updated 31 July 2025
What this trial tests

trial testing Ultrasound measurements in Superior Mesenteric Artery Syndrome in 289 participants. Currently enrolling.

Timeline
27 April 2020
Primary endpoint
30 December 2026
30 December 2026

Quick facts

Lead sponsorEnte Ospedaliero Cantonale, Bellinzona
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment289
Start date27 April 2020
Primary completion30 December 2026
Estimated completion30 December 2026
Sites2 locations across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Ente Ospedaliero Cantonale, Bellinzona — full company profile →

Who can join

Adults 10 to 15, any sex, with Superior Mesenteric Artery Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multicenter, prospective, observational research project on children aged from 10 to 15 years old undergoing abdominal ultrasound examinations during routine clinical practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ultrasound measurements

Trials testing the same drug.

Other Ente Ospedaliero Cantonale, Bellinzona trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04515251.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing